Transforming Neurodevelopmental Care
Autism and related neurodevelopmental conditions affect millions globally, presenting challenges in communication, learning, and social interaction. While traditional therapies have supported many individuals, families continue searching for more effective, personalised solutions.
The QPAN® Protocol, developed and published by Dr Alptekin Aydin, represents an advancement in personalised neuropsychological care. By combining advances in neuroscience with individualised therapeutic strategies, QPAN® creates a treatment approach that adapts to each person's progress.
"QPAN® represents a significant advancement in the field of neuromodulation and neurodevelopmental treatment. Our goal is to provide each patient with the most precise care, helping them achieve their full potential through a truly personalised approach." — Dr Alptekin Aydin, Founder of QPAN®
Unlike one-size-fits-all approaches, QPAN® uses sophisticated QEEG brain mapping to understand each individual's unique neurological profile. This data guides every aspect of treatment, from initial protocol design to ongoing adjustments based on measured progress.
Four Pillars of Precision Care
The QPAN® system integrates cutting-edge neuroscience technologies to create a comprehensive treatment protocol that adapts to each patient's unique neurological profile.
QEEG Brain Mapping
QEEG provides quantitative information about recorded electrical brain activity. Within QPAN®, eligible QEEG-derived measures can be organised alongside clinical information to support individualised review and longitudinal comparison. QEEG is not used as a stand-alone diagnostic test for autism and does not independently localise a treatment target or predict response.
- 19-channel recording system
- Comparison with defined reference datasets where appropriate
- Quantitative review of eligible EEG-derived measures
- Longitudinal comparison where clinically appropriate
Personalised NeuroMap® Guidance
NeuroMap® organises QEEG-derived measures and predefined analytical outputs to support structured clinician review and longitudinal comparison. Its outputs are decision-support information and do not independently establish diagnosis, treatment efficacy, an optimal treatment or a guaranteed outcome.
- Structured analytical outputs
- Longitudinal comparison
- Pattern review
- Clinician decision support
Targeted Neuromodulation
Using tDCS (transcranial Direct Current Stimulation) and TMS (Transcranial Magnetic Stimulation), we stimulate targeted brain regions to support cognitive function and behavioural outcomes through non-invasive, gentle sessions.
- Non-invasive and painless
- Precision-targeted stimulation
- CE-marked equipment
- Clinic and home-based options
Holistic Integration
Beyond neuromodulation, QPAN® combines traditional therapies including speech and language therapy, behavioural interventions, and tailored education and lifestyle recommendations for comprehensive care.
- Speech and language therapy
- Behavioural interventions
- Educational support
- Lifestyle guidance
Comprehensive Neurodevelopmental Care
Autism Spectrum
Autism-related QPAN® work focuses on research-led assessment, individual neurophysiological characterisation and longitudinal monitoring. Neuromodulation in autism remains an evolving area of research and is not presented as a cure or as a guaranteed means of changing communication, repetitive behaviour, social interaction or other autism-related features.
ADHD
Enhancing focus, attention regulation, and executive function through precision neuromodulation of frontal cortex networks.
Depression & Anxiety
Balancing neural systems and strengthening emotional regulation circuits for improved mood and resilience.
OCD
Modulating overactive neural circuits to reduce compulsive behaviours and intrusive thoughts while preserving healthy cognitive patterns.
Learning Difficulties
Addressing dyslexia, dyscalculia, and other specific learning difficulties through customised protocols based on individual brain mapping.
Cognitive Enhancement
Optimising brain performance for memory, processing speed, and executive function in both clinical and wellness applications.
Clinical and Research Monitoring
Clinical and research observations are reviewed using standardised measures and longitudinal data where available. Changes observed during clinical care or research are not equivalent to controlled evidence of treatment efficacy and should not be used to predict an individual outcome. Study design, concurrent interventions, natural development, measurement variability and other potential explanations are considered when interpreting change.
Note: Outcomes are based on clinical observations and family feedback. Individual results vary depending on presentation, engagement, and other factors. No specific outcome can be guaranteed. All treatments are provided as part of a comprehensive care programme alongside standard medical and psychological assessment. QPAN® does not replace medical diagnosis or treatment by appropriately qualified healthcare professionals.
Home-Based QPAN® Treatment
Dr Aydin developed home-based neuromodulation protocols guided by QEEG. Through our secure app-based system and CE-marked equipment, families worldwide can participate in QPAN® sessions from the comfort of their homes.
Families Worldwide
Participating in remote QPAN® sessions through our secure app-based system, managing treatment in the comfort of their homes.
Certified Equipment
CE-marked tDCS headsets enabling safe, clinically supervised home-based neuromodulation following individualised protocols.
Support Community
A private community of families worldwide sharing their experiences with the QPAN® model and supporting one another.
Begin Your QPAN® Journey
To learn more about how QPAN® may support you or your family member, please contact Cosmos Healthcare. Referrals are accepted from GPs, consultants, and self-referring individuals.